Drug Abuse and Intoxication
Sarah E. Norris
Pediatrics Hospice & Palliative Medicine<span style="box-sizing:inherit;color:#252525;font-family:Arial, Helvetica, sans-serif;font-size:20px;background-color:#ffffff;"></span>
Dr. Norris's research focus is on primary palliative care education and family decision making regarding medical technology.
<p>Sarah Evans Norris, MD, MEd, is Director of the Quality in Life Team and Director of Pediatric Palliative Care at Children?s Hospital at Montefiore. She is an Assistant Professor of Pediatrics and of Neurology at the Albert Einstein College of Medicine. </p><p>Dr. Norris earned her Bachelor of Science in Nursing at Loyola University Chicago in 1993 receiving the Gladys Kinnery Clinical Excellence award. As a nurse she worked around the globe including as a Peace Corps volunteer in Morocco before pursuing medical school at the Universidad Autonoma de Guadalajara in Mexico. She completed the Fifth Pathway Program through New York Medical College and embarked on her pediatrics internship at the University of Medicine & Dentistry New Jersey. She finished her residency at the Medical College of Georgia where she was named Resident of the Year. Following residency she completed a fellowship in pediatric critical care medicine and a masters in medical education at Cincinnati Children?s Medical Center. After several years in practice she returned to Cincinnati Children?s to complete a second fellowship in hospice and palliative medicine. Dr. Norris is Board Certified in General Pediatrics and in Hospice and Palliative Medicine.</p> <p>Dr. Norris? research focus is on primary palliative care education and family decision making regarding medical technology. She has given numerous presentations nationally and has a wide range of teaching experience with both adults and children internationally. In 2018 she received the Lewis Fraad Excellence in Resident Teaching Award. When she is not at CHAM you can find her running.</p>
Rachel H. Noone
<p class="x_MsoNormal">Rachel Noone, MD is an inpatient psychiatrist at Montefiore Medical Center Wakefield Division. She specializes in the treatment of individuals with severe persistent mental illness, including those with bipolar disorder and schizophrenia. Her interests include emergency psychiatry, and clinical research. She is also the Montefiore Wakefield Division Site Director for the Albert Einsteain College of Medicine 3rd year medical student clerkship in psychiatry. Dr. Noone completed her psychiatric residency at Montefiore Medical Center and also completed a two year research fellowship at the Montefiore Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program. She earned her MD from Pennsylvania State University College of Medicine, and completed college at The University of Pittsburgh with a dual major B.A. in film studies and business.</p>
<p class="x_MsoNormal"> </p>
<p class="x_MsoNormal"> </p>
Moyses Niremberg
Andrei Y. Nagorny
<p class="MsoNormal" style="line-height: 110%;"><span style="font-size: 10.5pt; line-height: 110%; font-family: 'Verdana',sans-serif;">Dr. Andrei Nagorny is a psychiatrist working on the inpatient psychiatric unit at Montefiore Hospital, Wakefield Division. His interests are in Inpatient Psychiatry, Emergency Psychiatry, Child and Adolescent Psychiatry, Psychotherapy, Consultation Liaison Psychiatry, and Substance Abuse. As a clinician, educator, and Assistant Professor on the faculty at Montefiore Hospital/Albert Einstein College of Medicine, Dr. Nagorny has been involved in the training of medical students, residents, and fellows. </span><span style="font-size: 10.5pt; line-height: 110%; font-family: 'Verdana',sans-serif;">Dr. Nagorny is currently Director of inpatient psychiatry services at Montefiore Hospital Center, Wakefiled Division. He is dually board certified in both Adult and Child & Adolescent Psychiatry. Dr. Nagorny completed his Adult Psychiatry Residency and Child Adolescent Psychiatry Fellowship at Bronx Lebanon Hospital Center/Albert Einstein College of Medicine. He also holds a Master of Science degree in Social Work from Columbia University, and is a Licensed Clinical Social Worker. </span></p>
Adele T. Munsayac
<p style="margin: 0in 0in 10pt;"><span style="line-height: 115%; font-size: 12pt;"><span style="font-family: Calibri;">Dr. Adele T. Munsayac is a board-certified psychiatrist with over 28 years of experience treating adults, adolescents and children in a variety of settings. While she primarily focuses on emergency room assessment, diagnosis and crisis intervention, she is also a provider in the Adult Outpatient Department of Psychiatry at the Moses campus. She provides lectures to first-year psychiatry residents centered on emergency evaluations and crisis intervention for children and adolescents, and supervises residents, Child fellows, medical students, Psychology Interns, and Social Workers</span></span></p>
<p><span style="color: black; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><span style="font-size: medium;">Dr. Munsayac completed her residency in General Psychiatry at Nassau University Medical Center in Long Island, NY, and her Child and Adolescent Psychiatry fellowship at Montefiore Medical Center/AECOM. She is also a Fellow of the American Psychiatric Association. </span></span></p>
<p><span style="color: black; font-family: 'Verdana','sans-serif'; font-size: 7.5pt;"> </span></p>
<p> </p>
Solomon L. Moshe
<p><strong>Solomon L. Moshé, M.D., </strong>is the Charles Frost Chair in Neurosurgery and Neurology, and Professor of Neurology, Neuroscience, and Pediatrics at the Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx, New York. He is also the Vice Chair of the Saul R. Korey Department of Neurology, Director of the Isabelle Rapin Child Neurology Division and Director of Clinical Neurophysiology. His area of expertise is in epilepsy and related disorders.</p>
<p>Since 1979, his research has focused on understanding the mechanisms underlying age and sex-related differences in epilepsy in humans and animal models. Current research interests include studies on the role of subcortical circuitries involved in the control of seizures as a function of age and sex; the consequences of seizures on the developing brain and the development of models of catastrophic epilepsies. His laboratory has patented a model of infantile spasms that can be used to identify novel treatments. He is co principal investigator of a Center Without Walls grant on interdisciplinary research aimed at accelerating the development of disease modifying or prevention therapies for epilepsy following traumatic brain injuries. He is also involved in a large multicenter study examining the consequences of prolonged febrile seizures. He has over 600 publications as well as He has over 600 publications as well over 35 books and monographs.</p>
<p>He has served as President of the International League Against Epilepsy (2009-2013), the American Epilepsy Society (2000-2001), the American Clinical Neurophysiology Society (1996-1997) and the Eastern Association of EEGers (1992-1994). He is the recipient of many awards and honors, including the Teacher-Investigator Development Award from NINDS; the 1995 Jacob Javits Neuroscience Investigator Award from NINDS; the 1984 Michael Prize for Achievements in Epilepsy Research; the 1990 American Epilepsy Society Research Award; the 1999 Ambassador for Epilepsy Award from the International League Against Epilepsy; the 2005 Gloor Award from the American Clinical Neurophysiology Society; the 2007 J.E. Purkyne Honorary Medal in Biomedical Research by the Czech Academy of Sciences; the 2008 Mentor of the Year Award from Albert Einstein College of Medicine; the 2010 Global and Awareness Award from CURE, Citizens United for Research in Epilepsy; the First 2012 Saul R. Korey Award in Translational Science and Medicine, Albert Einstein College of Medicine and the 2017 Bernard Sachs Award from the Child Neurology Society, and the 2023 Lifetime Achievement Award from the International League against Epilepsy.</p>
<p>He has been asked to deliver over 50 several keynote lectures.</p>
<h6>Clinical Focus</h6>
<p>Dr. Moshé focuses on helping people with epilepsy and related conditions with a special emphasis on children and adolescents.</p>
<h6>Research focus</h6>
<p>Dr Moshé has focused on translational research to understand the mechanisms underlying age and sex-related differences in epilepsy in humans and animal models. The main goals are to develop individualized treatments today and to prevent and cure epilepsy tomorrow. Current projects include the development of effective means to predict and treat epilepsy after traumatic brain injury and the development of specialized treatments for infants and children with epilepsy.</p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt; font-family: "Arial","sans-serif";">Dr. Moshé is an authority on the mechanisms that underlie the development of epilepsy and on the consequences of the disease in infants and children.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt; font-family: "Arial","sans-serif";">A translational scientist, Dr. Moshé has developed and patented an animal model that replicates human infantile spasms, which can be used to identify novel treatments of this devastating condition. Dr. Moshé has served as President of the International League Against Epilepsy, American Epilepsy Society, the American Clinical Neurophysiology Society, and the Eastern Association of Electroencephalographers.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt; font-family: "Arial","sans-serif";">Dr. Moshé is actively involved in several large, multicenter studies examining the outcomes of prolonged febrile seizure to identify predictive biomarkers of the course of these conditions and response to treatment.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt; font-family: "Arial","sans-serif";">Dr. Moshé has received numerous honors and awards, including the American Epilepsy Society Research Recognition Award, Jacob Javitz Neuroscience Investigator Award from the National Institutes of Health, the Michael Prize, American Epilepsy Society research award, the CURE (Citizens United for Research in Epilepsy) Global Awareness Award for leadership in raising the international profile of epilepsy<strong>, </strong>the Pierre Gloor Award of the American Clinical Neurophysiology Society, and the J.E. Purkyne Honorary Medal for Merit in the BioMedical Sciences of the Czech Academy of Sciences. He is an elected member of the American Neurological Association and the American Pediatric Society. </span></p>
Dr. Moshé focuses on helping people with epilepsy and related conditions with a special emphasis on children and adolescents
Dr. Moshé has focused on translational research to understand the mechanisms underlying age and sex-related differences in epilepsy in human and animal models. The main goals are to develop individualized treatments today and to prevent and cure epilepsy tomorrow. Current projects include the development of effective means to predict and treat epilepsy after traumatic brain injury and the development of specialized treatments for infants and children with epilepsy.
<h6>Book</h6>
<ol>
<li>Engel J and Moshé SL, Editors-In-Chief. Epilepsy: A Comprehensive Textbook, 3rd Edition. Wolters Kluwer (2024).</li>
</ol>
<h6>Publications</h6>
<ol>
<li>Wirrell E, Tinuper P, Perucca E and Moshé SL. Introduction to the epilepsy syndrome papers. Epilepsia, 63, 1330-1332 (2022) PMID: 35503711</li>
<li>Zuberi S, Wirrell E, Yozawitz E, Wilmshurst J, Specchi N, Riney K, Pressler R, Auvin S, Samia P, Hirsch E, Galicchio S, Triki C, Snead O, Wiebe S, Cross H, Tinuper P, Scheffer I, Perucca E and Moshé SL. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 63, 1349-1397 (2022) PMID: 35503712</li>
<li> Hirsch E, French J, Scheffer I, Bogacz A, Alsaadi T, Sperling M, Abdulla F, Zuberi S, Trinka E, Specchio N, Somerville E, Samia P, Riney K, Nabbout R, Jain S, Wilmshurst J, Auvin S, Wiebe S, Perucca E, Moshé SL, Tinuper P and Wirrell E. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 63, 1475-1499 (2022) PMID: 35503716</li>
<li> Specchio N, Wirrell E, Scheffer I, Nabbout R, Riney K, Samia P, Guerreiro M, Gwer S, Zuberi S, Wilmshurst J, Yozawitz E, Pressler R, Hirsch E, Wiebe S, Cross H, Perucca E, Moshé SL, Tinuper P and Auvin S. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia, 63, 1398-1442 (2022) PMID: 35503717</li>
<li> Riney K, Bogacz A, Somerville E, Hirsch E, Nabbout R, Scheffer I, Zuberi S, Alsaadi T, Jain S, French J, Specchio N, Trinka E, Wiebe S, Auvin S, Cabral-Lin L, Naiddo A, Perucca E, Moshé SL, Wirrell E and Tinuper P. International League Againist Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia, 63, 1443-1474 (2022) PMID: 35503725</li>
<li> Auvin S, Galanopoulou AG, Moshé SL, Potschka H, Rocha L, Walker M. Revisiting the concept of drug-resistant epilepsy. A TASK1 report of the ILAE/AES Translational Task Force. Epilepsia 1-18 2023. </li>
<li> Samfira M, Galanopoulou AS, Nariai H and Moshé SL. EEG-based spatiotemporal dynamics of fast ripple networks and hubs in infantile epileptic spasms. Epilepsia 1-16. 2023. </li>
<li> Scott R, Holmes G and Moshé SL. Do Vaccines Cause Epilepsy? Review of Cases in The National Vaccine Injury Compensation Program. Epilespia 1-60. 2023 PMID: 37914395</li>
<li> Lucasius C, Grigorovsky V, Nariai H, Galanopoulou AS, Gursky J, Moshé SL, Bardakjian B. Biomimetic Deep Learning Networks with Applications to Epileptic Spasms and Seizures Prediction. IEEE Transactions on Biomedical Engineering (TBME) 1056-1067. 2023 PMID: 37851549</li>
<li> Galanopoulou AS, Auvin S, Moshé SL, Potschka H, Rocha L and Walker M. Response: <a target="_blank" rel="noopener noreferrer">Drug resistance in epilepsy: a reappraisal of the definition is needed</a>. Epilepsia 1-2 2023 PMID: 37921052</li>
<li> Pease M, Gupta K, Moshé SL, Correa D, Galanopoulou AS, Okonkwo D, Gonzalez-Martinez J, Shutter L, Diaz-Arrasta R, and Castellano J. Insights into epileptogensis from post-traumatic epilepsy. Nature Reviews Neurology 20, 298-312. 2024. PMID: 38570704</li>
<li> Lewis D, Voyvodic J, Shinnar S, Chan S, Bello J, Moshé SL, Nordli Jr D, Frank M, Pellock J, Hesdorffer D, Xu Y, Shinnar R, Seinfeild S, Epstein L, Masur D, Gallentine W, Weiss E, Deng X and Sun S. Hippocampal Sclerosis and Temporal Lobe Epilepsy following Febrile Status Epilepticus: The FEBSTAT Study. Epilepsia 65, 1568-1580. 2024. PMID: 38606600</li>
<li> De Meulemeester A, Reid C, Auvin S, Carlen P, Cole A, Szlendak R, Di Sapia R, Moshé SL, Sankar R, O’Brien T, Baulac S, Henshall D, Akman O, Galanopoulou AS. WONOEP appraisal 2022: modeling early-onset epilepsies. Epilepsia 65, 2553-2566. 2024. PMID: 39042520</li>
<li> Li C, Casillas-Espinosa P, Grandizoli P, Chi T, Yamkawa G, Silva, Hudson, Liu W, Jones N, Shultz S, Ali I, Mishra U, Cloyd J, Moshé SL, Galanopoulou AS and O’Brien T. Pharmacokinetics and Brain Uptake of Sodium Selenate and Selenium in Naïve Rats and a Lateral Fluid Percussion Injury Rat Model. Journal of Pharmacology Research & Perspectives 1-14. PMID: 39506350</li>
<li> Quatraccioni A, Cases-Cunillera S, Balagura G, Coleman M, Rossini L, Mills J, Casillas-Epinosa P, Moshe SL, Sankar R, Baulac S, Noebels J, Auvin S, O’Brien T, Henshall D, Akman O and Galanopoulou AS. WONOEP appraisal: Genetic insights into early-onset epilepsies. Epilepsia 65, 3138-3154. 2024. </li>
<li> Bruckhaus A, Asifriyaz T, Kriukova K, O’Brien T, Agoston D, Staba R, Jones N, Moshé SL, Galanopoulou AS and Dunca D. Exploring Multimodal Biomarker Candidates of Post-Traumatic Epilepsy Following Moderate to Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Epilepsia 00, 1-27 2024</li>
<li> Nunes M, Yozawitz E, Wusthoff C, Shellhaas R, Olivas-Pena E, Wilmshurst J, Pressler R, Triki C, Hartmann H, Inder T, Boylan G, Valenta K, Moshe SL, Mizrahi E and Abend N. Defining Neonatal Status Epilepticus: A Scoping Review from the ILAE Neonatal Task Force. Epilepsia Open 1-15. 2024. PMID: 39540265</li>
<li> Yozawitz E, Cilio M, Mizrahi E, Moon J, Moshé SL, Nunes M, Plouin P, Zuberi S and Pressler R. ILAE Neonatal Seizure Framework to Aide in Determining Etiology. Epileptic Disorders 1-7. 2024. </li>
<li> Sandra O, Wang Y, Coles L, Mowrey W, Li Q, Liu W, Moshé SL and Galanopoulou AS. Efficacy and tolerability of celastrol and edaravone in the multiple-hit rat model of infantile spasms. Epilepsy & Behavior 1-14. 2024. PMID: 39577370.</li>
<li> Carapancea E, Eizadkhah D, Santalucia R, Lederer D, Arts F, Lagae L, Moshé SL and Cilio M. Epilepsy phenotype and developmental outcome in girls with mosaicism in X-linked neurodevelopmental disorders. Epileptic Disorders 1-10 2025</li>
</ol>
<p>Solomon L. Moshé, MD, is Vice Chair of Neurology, Director of the Isabelle Rapin Child Neurology Division and Director of Clinical Neurophysiology at Montefiore. He is also the Charles Frost Chair in Neurosurgery and Neurology, Vice Chair, Saul R. Korey Department of Neurology, and Professor of Neurology, Neuroscience and Pediatrics at the Albert Einstein College of Medicine (Einstein). Dr. Moshé’s clinical focus is on epilepsy and electroencephalography with special emphasis on age-related influences on the expression, control and consequences of seizures.</p><p>After receiving his Doctor of Medicine from the National University of Athens School of Medicine in Greece in 1972, Dr. Moshé began his post-doctoral training at the University Hospital of Maryland. He completed his internship and residency there in pediatrics in 1975. Following this, he pursued a pediatric neurology fellowship at Einstein from 1975 to 1978. He was a visiting epilepsy research fellow at the University of California Los Angeles in 1978, then completed a neurology and neuroscience research fellowship at Einstein in 1979. He was a guest scholar with the EEG department at Columbia Presbyterian Medical Center from 1980 to 198, and with the seizure unit at Children’s Hospital in Boston in 1980.</p><p>Dr. Moshé’s research focuses on understanding the mechanisms underlying differences in epilepsy in humans and animal models. His laboratory has developed and patented a novel model of human infantile spasms that can be used to identify novel treatments of this devastating condition. He also investigates the consequences of prolonged seizures and methods to accelerate the development of disease modifying or prevention therapies for post-traumatic epilepsy. His extensive body of work has been shared nationally and internationally through peer-reviewed publications, lectures and conferences. He is a member on several editorial boards including Neurobiology of Disease, Pediatric Neurology, Epileptic Disorders, and the Journal of Neurology & Psychology.</p><p>Dr. Moshé has been recognized with numerous national and international honors and awards, including a 1995 Jacob Javits Neuroscience Investigator Award from the National Institute of Health, the first 2012 Saul R. Korey Award in Translational Science and Medicine, Albert Einstein College of Medicine; the 2017 Bernard Sachs Award from the Child Neurology Society, and election as a foreign member of the Russian Academy of Science in 2017. He is a member of many professional societies including the American Academy of Neurology, the Child Neurology Society, the American Epilepsy Society and the American Association for Advancement of Science.</p>
Kerry A. Morrone
<p>Anemia, hospitalist medicine, general pediatrics</p>
Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.
Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research
<p>Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.</p><p>Dr. Morrone graduated from New York University, earning her Bachelor of Arts in Biology in 2003. She then attended the Albert Einstein College of Medicine, where she received her Doctor of Medicine in 2007 and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Morrone completed her pediatric residency, chief residency, and pediatric hematology oncology fellowship all at the Albert Einstein College of Medicine. She has also been recognized for her teaching efforts many times and won the Leo M. Davidoff Society – Albert Einstein College of Medicine Teaching Award in 2010 and 2015.</p><p>Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research. Other current research interests include pulmonary complications of sickle cell disease particularly asthma and acute chest syndrome, in addition to infectious complications and thrombotic complications of sickle cell disease.</p>
Haleh Moazen
Maria Y. Mazing
<p>My research interest is in internal medicine/hospital medicine.</p>